NEVIRAPINE APOTEX nevirapine 200 mg tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

nevirapine, Quantity: 200 mg

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

Nevirapine

Darreichungsform:

Tablet

Zusammensetzung:

Excipient Ingredients: magnesium stearate; lactose; microcrystalline cellulose; crospovidone; copovidone

Verabreichungsweg:

Oral

Einheiten im Paket:

60

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Nevirapine immediate-release tablets in combination with antiretroviral agents are indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years.,Resistant virus emerges rapidly when nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

Produktbesonderheiten:

Visual Identification: white, oval shaped scored biconvex tablets with engraved "APO" and bisect on one side and "NAV" bisect "200" on the other side; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2016-03-17